Eli Lilly and Company logo
Eli Lilly and Company LLY
€ 780.52 0.35%

Geschäftsbericht 2025
hinzugefügt 12.02.2026

report update icon

Eli Lilly and Company DSO 2011-2026 | LLY

DSO Jährlich Eli Lilly and Company

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
80.5 81.4 85.5 86.8 80.9 77.5 90.6 92.2 84 82 74.5 70.7 63.5 62.8 63.7

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
92.2 62.8 78.4

DSO Vierteljährlich Eli Lilly and Company

2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
76.9 80 85 76.3 83.5 75.3 82.6 94.5 - 44.1 44.5 75.9 - 79.1 77.3 76.9 - 93.4 97.5 81.2 67.9 75.8 73.6 81.9 74.4 79 75.1 78.8 71.9 83.6 81.5 86.7 63.8 70.8 68 70.7 59.6 64.6 64.4 66.3 57.6 60.5 59.8 65 54 54.3 52.9 55.1 51.1 55.9 54.4 56.5 - 53.4 52.5 -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
97.5 44.1 69.9

DSO anderer Aktien in der Pharmaeinzelhändler

Name DSO Preis % 24h Marktkapitalisierung Land
Scholar Rock Holding Corporation Scholar Rock Holding Corporation
SRRK
445 $ 43.62 -1.33 % $ 5 B usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
146 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
216 - - $ 1.01 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
84.7 - - $ 40.3 B usaUSA
Albireo Pharma Albireo Pharma
ALBO
14.7 - -0.23 % $ 916 M usaUSA
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
204 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.75 K - -1.52 % $ 24.7 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
946 - -6.81 % $ 3.04 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
0.114 - - $ 26.5 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
Acorda Therapeutics Acorda Therapeutics
ACOR
48.3 - -24.86 % $ 820 K usaUSA
bluebird bio bluebird bio
BLUE
2.47 - - $ 546 M usaUSA
Acasti Pharma Acasti Pharma
ACST
1.97 - 4.01 % $ 150 M canadaCanada
Avid Bioservices Avid Bioservices
CDMO
45.6 - - $ 789 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
222 - - $ 86.2 M usaUSA
Advaxis Advaxis
ADXS
88.1 - -9.65 % $ 45.9 M usaUSA
Stoke Therapeutics Stoke Therapeutics
STOK
7.52 $ 33.98 0.83 % $ 2.01 B usaUSA
EyePoint Pharmaceuticals EyePoint Pharmaceuticals
EYPT
7.32 $ 13.09 0.23 % $ 959 K usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
China SXT Pharmaceuticals China SXT Pharmaceuticals
SXTC
318 $ 1.38 4.55 % $ 1.96 M chinaChina
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
TAK
79.3 $ 18.16 0.55 % $ 28.4 B japanJapan
BioDelivery Sciences International BioDelivery Sciences International
BDSI
115 - -4.8 % $ 255 M usaUSA
Cara Therapeutics Cara Therapeutics
CARA
52.4 - -3.03 % $ 260 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
3.1 - - $ 3.74 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
13.6 - - $ 867 M germanyGermany
Equillium Equillium
EQ
16.6 $ 2.06 - $ 118 M usaUSA
Theravance Biopharma Theravance Biopharma
TBPH
251 $ 14.97 -1.45 % $ 753 M cayman-islandsCayman-islands
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
39.1 $ 23.43 -0.09 % $ 630 M usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
1.1 K $ 47.18 -0.79 % $ 4.24 B schweizSchweiz
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
50 $ 4.46 0.22 % $ 855 M canadaCanada